Ainos Shares Jump on First Commercial Orders for AI Nose in Semiconductor Sector

Shares of Ainos Inc. (NASDAQ:AIMD) rose 6.9% in premarket trading on Monday after the company announced it has secured its first commercial orders for the AI Nose platform from a front-end semiconductor manufacturer.

The development marks a significant milestone for Ainos, signaling its transition from technical validation activities to commercial deployment and revenue generation, which the company expects to begin in the second half of 2026.

Commercial Milestone

The initial orders follow a validation phase that began in March, during which Ainos deployed approximately 200 of its AI Nose systems in wafer fabrication facilities, according to the company's statement. The technology is designed to digitize chemical signatures within complex manufacturing environments.

By providing a "chemical perception layer," the platform complements traditional vision and audio monitoring systems. It is being deployed across both front-end wafer fabrication and back-end packaging and testing processes, where precise chemical monitoring can indicate changes in process conditions, equipment performance, and environmental factors.

Ad

Technology and Data Strategy

Ainos positions its AI Nose as a key part of a broader "Chemical Intelligence" strategy. The second-generation platform, launched in August, included upgrades to its software, edge AI capabilities, and hardware reliability.

Separately, Ainos announced its proprietary real-world chemical dataset has surpassed 1 billion records, a notable increase from the 878 million records reported in August. The company emphasized that this dataset is generated by its systems operating in real-world environments, rather than from simulated or internet-sourced data. Each deployed sensor serves customers while also contributing data to Ainos's central intelligence infrastructure.